Interactive case discussion: what are the clinical implications of cardiovascular outcomes of SGLT2 inhibition?

HFA Premium Access

Interactive case discussion: what are the clinical implications of cardiovascular outcomes of SGLT2 inhibition?

Session: Novel strategies for addressing diabetes & heart failure: evaluating cardiovascular outcomes

Topic: Chronic heart failure

Speaker: Professor S. Anker (Berlin, DE) Doctor D. Fitchett (Toronto, CA)

Organised by the Physicians Academy for Cardiovascular Education (PACE) Foundation / Course Director: Prof Adriaan A Voors / Supported by an unrestricted educational grant from Boehringer Ingelheim

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speakers

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

171 presentations

11 followers

Doctor David Fitchett

St. Michael's Hospital, Toronto (Canada)

18 presentations

0 follower

2 more presentations in this session

Introduction.

Speaker: Professor S. Anker (Berlin, DE)

Access

Cardiovascular outcomes of SGLT2 inhibition: evidence from recent clinical trials.

Speaker: Doctor D. Fitchett (Toronto, CA)

Access

Access the full session

Novel strategies for addressing diabetes & heart failure: evaluating cardiovascular outcomes

Speakers: Professor S. Anker, Doctor D. Fitchett, Professor S. Anker, Doctor D. Fitchett

Access

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources